Latest News & Features
Big Pharma
Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 28 August 2018
Americas
Bryan Roberts was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 27 August 2018
Americas
A Wisconsin jury has concluded that medical device company DePuy Synthes should pay $8.2 million for wilfully infringing an orthopaedic implant patent. 27 August 2018
Asia-Pacific
York Faulkner, an IP partner from Finnegan, Henderson, Farabow, Garrett & Dunner, has joined Quinn Emanuel Urquhart & Sullivan in Tokyo. 24 August 2018
Big Pharma
The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market. 24 August 2018
Americas
Jim Tananbaum was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 24 August 2018
Americas
A non-profit called AIDS Healthcare Foundation has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead. 23 August 2018
Big Pharma
Danish healthcare company Novo Nordisk has entered into an alliance with Germany-based Evotec to develop treatments for diabetes and obesity. 23 August 2018
Americas
Craig Muir was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 23 August 2018
Big Pharma
The European Commission’s proposed export waiver for supplementary protection certificates is likely to face opposition and may be delayed by EU parliamentary changes, says Trevor Cook of WilmerHale. 23 August 2018